| RS1688274473 |
COL3A1
|
Health Risk |
Likely pathogenic |
Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome, Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome |
| RS1688293940 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1688304002 |
COL3A1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1688305296 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688308445 |
CERKL
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 26, Retinitis pigmentosa 26 |
| RS1688322272 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688322811 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688324714 |
GALNT3
|
Health Risk |
Likely pathogenic |
— |
| RS1688360581 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1688384382 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688402212 |
COL3A1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1688417659 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688418367 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688419519 |
GALNT3
|
Health Risk |
Likely pathogenic |
— |
| RS1688433173 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1688456281 |
RYR2
|
Health Risk |
Likely pathogenic |
Conduction disorder of the heart, Conduction disorder of the heart |
| RS1688479407 |
HECW2
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with hypotonia, seizures |
| RS1688479620 |
HECW2
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, seizures |
| RS1688481563 |
HECW2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, seizures |
| RS1688487502 |
PROC
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1688502787 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS1688507660 |
GALNT3
|
Health Risk |
Likely pathogenic |
— |
| RS1688528616 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688529460 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688530172 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688532582 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688544768 |
BMPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary hypertension, primary |
| RS1688558323 |
GALNT3
|
Health Risk |
Likely pathogenic |
— |
| RS1688559190 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Idiopathic and/or familial pulmonary arterial hypertension |
| RS1688559718 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1688560182 |
SMPD4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, arthrogryposis |
| RS1688561621 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS1688561668 |
COL3A1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1688561706 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688568929 |
BMPR2
|
Health Risk |
Pathogenic |
— |
| RS1688583785 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS1688586251 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688619749 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688630479 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS1688635593 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688636055 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1688653833 |
CERKL
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 26, Retinal dystrophy |
| RS1688654801 |
CERKL
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1688656690 |
CTLA4
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency |
| RS1688657241 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1688663336 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688667609 |
PROC
|
Health Risk |
Likely pathogenic |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1688669245 |
PROC
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1688675737 |
SMPD4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, arthrogryposis |
| RS1688677671 |
PROC
|
Health Risk |
Likely pathogenic |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1688692269 |
PROC
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1688692415 |
PROC
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1688706133 |
PROC
|
Health Risk |
Pathogenic |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1688706297 |
PROC
|
Health Risk |
Likely pathogenic |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1688711686 |
CTLA4
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency |
| RS1688712720 |
CTLA4
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency |
| RS1688714312 |
CTLA4
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency |
| RS1688714490 |
CTLA4
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency |
| RS1688714703 |
CTLA4
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency |
| RS1688715336 |
CTLA4
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency |
| RS1688716836 |
CTLA4
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency |
| RS1688717281 |
CTLA4
|
Health Risk |
Pathogenic |
— |
| RS1688718864 |
CTLA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Inborn genetic diseases |
| RS1688726478 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS1688726794 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1688729428 |
CTLA4
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency |
| RS1688730155 |
CTLA4
|
Health Risk |
Pathogenic |
— |
| RS1688730568 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688731180 |
CTLA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome |
| RS1688732322 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688736712 |
SATB2
|
Health Risk |
Likely pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1688740919 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1688794902 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1688812000 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1688921542 |
TTN
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1688922276 |
ITGAV
|
Health Risk |
Pathogenic/Likely pathogenic |
IMMUNE DYSREGULATION, NEURODEVELOPMENTAL DEFECTS |
| RS1689007552 |
CERKL
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 26, Retinal dystrophy |
| RS1689010156 |
CERKL
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 26 |
| RS1689011389 |
CERKL
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1689012192 |
CERKL
|
Health Risk |
Pathogenic |
Cone-rod dystrophy, Cone-rod dystrophy |
| RS1689079381 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS1689136140 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689139851 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1689142827 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689146216 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1689156608 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689186812 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1689190343 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
SCN1A-related epilepsy syndrome, recessive |
| RS1689200375 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689207347 |
SCN1A
|
Health Risk |
Likely pathogenic |
SCN1A-related channelopathy, SCN1A-related channelopathy |
| RS1689211569 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689211960 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS16892134 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel syndrome, type 6 |
| RS1689218857 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689226880 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1689228485 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1689240616 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689241423 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1689242255 |
SCN1A
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS1689245014 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |